Member of Farmavita.net is offering dossier in European CTD format for Topiramate, 25 – 100 – 200 mg.  

Dossier is ready, not submitted. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.  

Topiramate is classified as a nervous system medicine, according ATC index.

Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. 

Comments

Search RSS

Administrator  - Migraine - New Indication   |SAdministrator |2008-08-22 09:35:32 A new indication, the prophylaxis of migraine headache, approved in 2004 and a significant growth in sales in the US despite current economic downturn, suggests that topiramate is likely to attract the attention of generic manufacturers around the world.

Only registered users can write comments!

Powered by !JoomlaComment 3.20

3.20 Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• 3rd Annual Biosimilars conference (24/11/2008)
• Croatia - Pharmaceuticals and Biotechnology (18/10/2008)
• Leading Drug Delivery Companies and Technologies (14/10/2008)

• Sumatriptane (10/07/2006)
• Sertraline (10/07/2006)
• Salbutamol HFA (10/07/2006)
• Perinodopril (10/07/2006)
• Pamidronate (10/07/2006)
• Paclitaxel (10/07/2006)
• Oxaliplatin (10/07/2006)
• Omeprazole, capsules (10/07/2006)
• Misoprostol (10/07/2006)